Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins

Journal of Lipid Research

Volumn 41, Issue 2, 2000, Pages 269-276

  Qin, Shucun ^a   Kawano, Koichi ^a   Bruce, Can ^a   Lin, Min ^a   Bisgaier, Charles ^b   Tall, Alan R ^a   Jiang, Xian Cheng ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Esperion Therapeutics Inc   (United States)

Author keywords

Apolipoproteins; Fractional catabolic rate; HDL; Lipoproteins; Phospholipids

Indexed keywords

APOLIPOPROTEIN A4; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATABOLISM; ELECTRON MICROSCOPY; FEMALE; IMMUNOBLOTTING; KNOCKOUT GENE; LIPOLYSIS; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOLIPOPROTEINS E; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; FEMALE; KINETICS; LIPOPROTEINS, HDL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MODELS, BIOLOGICAL; PARTICLE SIZE; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS;

EID: 0033996833     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Tall, A. R. 1986. Plasma lipid transfer proteins. J. Lipid Res. 27: 361-367.
2. Day, J. R., J. J. Albers, C. E. Lofton-Day, T. L. Gilbert, A. F. T. Ching, F. J. Grant, P. J. O'Hara, S. M. Marcovina, and J. L. Adolphson. 1994. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 269: 9388-9391.
3. Rye K. A., M. Jauhiainen, P. J. Barter, and C. Ehnholm. 1998. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J. Lipid Res. 39: 613-622.
4. Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
5. Tollefson, J. H., S. Ravnik, and J. J. Albers. 1988. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602.
6. Jiang, X., O. L. Francone, C. Bruce, R. Milne, J. Mar, A. Walsh, J. L. Breslow, and A. R. Tall. 1996. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J. Clin. Invest. 98: 2373-2380.
7. Ehnholm, S., K. W. van Dijk, B. van 't Hof, A. van der Zee, V. M. Olkkonen, M. Jauhiainen, M. Hofker, L. Havekes, and C. Ehnholm. 1998. Adenovirus-mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39: 1248-1253.
8. Foger, B., S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer, Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272: 27393-27400.
9. Jiang, X-c., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
10. Rinninger, F., N. Wang, R. Ramakrishnan, X-c. Jiang, and A. R. Tall. 1999. Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 19: 1325-1332.
11. 131I-labeled plasma proteins. Phys. Med. Biol. 2: 36-53.
12. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1994. Human HDL cholesterol levels are determined by apoAI fractional rate, which correlates inversely wilh estimates of HDL particle size. Arterioscler. Thromb. 14: 707-720.
13. Plump, A. S., N. Azrolan, H. Odaka, X-c. Jiang, A. Tall, S. Eisenberg, and J. L. Breslow. 1997. ApoAI knock-out mice have diminished HDL and non-HDL cholesterol levels, HDL cholestery ester flux, and tissue uptake of HDL cholesteryl esters but no evidence for increased peripheral tissue cholesterol accumulation to indicate diminished reverse cholesterol transport. J. Lipid Res. 38: 1033-1047.
14. Schaefer, E. J., C. B. Blum, R. I. Levy, L. L. Jenkins, P. Alanpovic, D. M. Foster, and H. B. Brewer, Jr. 1978. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N. Engl. J. Med. 299: 905-910.
15. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. Kastelein, and M. R. Hayden, 1999. Mutations in ABCI in Tangier Disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
16. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W. E. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K. J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
17. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H.B. Brewer, N. Duverger, P. Denelle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22: 352-355.
18. Forte, T. M., J. K. Bielicki, R. Goth-Goldstein, J. Selmek, and M. R. McCall. 1995. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36: 148-157.
19. Young, S., and C. J. Fielding. 1999. The ABCs of cholesterol efflux. Nat. Genet. 22: 316-318.
20. Jones, J. W., and P. Ways. 1967 Abnormalities of high density lipoproteins in abetalipoproteinemia. J. Clin. Invest. 46: 1151-1156.
21. Raabe, M., M. M. Veniant, M. A. Sullivan, C. H. Zlot, J. Bjorkegren, L. B. Nielsen, J. S. Wong, R. L. Hamilton, and S. G. Young. 1999. Analysis of the role of microsomal triglycerice transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103: 1287-1298.
22. Chang, B. H., W. Liao, L. Li, M. Nakamuta, D. Mack, and L. Chan. 1999. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knock-out mouse. J. Biol. Chem. 274:6051-6055.
23. Ikewaki, K., D. J. Rader, L. A. Zech, and H. B. Brewer, Jr. 1994. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism. J. Lipid Res. 35: 1809-1819.
24. Wolfbauer, G., J. J. Albers, and J. F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophysi. Acta. 1439: 65-76.
25. Wittrup, H. H., A. Tybjaerg-Hansen, and B. G. Nordestgaard. 1999. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart desease. A meta-analysis. Circulation. 99: 2901-2907.
26. Hayek, T., L. Masucci-Magoulas, X-c. Jiang, A. Walsh, E. Rubin, J. L. Breslow, and A. R. Tall. 1995. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transgene. J. Clin. Invest. 96: 2071-2074.
27. Hamilton, R. L., A. Moorehouse, and R. J. Havel. 1991. Isolation and properties of mascent lipoproteins from highly purified rat hepatocytic Golgi fractions. J. Lipid Res. 32: 529-543.
28. Schissel, S. L., J Tweedie-Hardman, J. H. Rapp, G. Graham, K. J. Williams, and I. Tabas. 1996. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyclin of retained low density lipoprotein. J. Clin. Invest. 98: 1455-1464.
29. Barter, P.J., O. V. Rajaram, L. B. Chang, K. A. Rye, P. Gambert, L. Lagrost, C. Ehnholm, and N. H. Fidge. 1988. Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator. Biochem. J. 254: 179-184.
30. Bergeron, A., L. Kotite, M. Verges, P. Blanche, R. L. Hamilton, R. Krauss, A. Bensadoun, and R. J. Havel. 1998. Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase. Proc. Natl. Acad. Sci. USA. 95: 15647-15652.